Ben Perry is Open Innovation Leader at Drugs for Neglected Diseases initiative (DNDi). Ben is a medicinal chemist with over 15 years’ experience conducting early stage drug discovery across a variety of disease indications including oncology, autoimmune disorders, and psychiatry. At DNDi, he is responsible for open innovation / open science drug discovery including international collaborations bringing together DNDi and pharmaceutical companies. The project aims at speeding up the process and reducing the cost of finding new treatments for Chagas disease and leishmaniasis.